Bookmark Article
The Indian pharmaceutical industry has been granted approval to produce peptide diabetes drugs under the Production Linked Incentive (PLI) scheme. This move will not only boost the production of essential medications for diabetes patients but also create new job opportunities in the sector. The Pharma department is hopeful that this initiative will help make these life-saving drugs more accessible and affordable for those in need.
Source link
